ViTrox Corporation Berhad’s Post

We're peresent at the ACS Conference! Representing us at the event is Kishore V Renduchintala, Our Executive Vice President & Head of Discovery Services and Vidya Sagar K. - Head of Business Development - Discovery Services. Meet us at the ACS Conference to learn more about Laxai and explore a partnership that could revolutionise the approach to drug discovery and development. To book a meeting, reach out to [email protected]. We look forward to connecting with you at the event! hashtag #ACSConference #LAXAI #DrugDiscovery #CRDMO #SmallMolecules

✨At DTx Asia, our Co-founder and CEO, Abhishek Shah, shared valuable insights on the evolution of a Digital Therapeutics (DTx) business. His talk illuminated the effectiveness of DTx; while acknowledging the hurdles in achieving broad market impact. He highlighted the intensive journey pharma companies face in establishing and expanding DTx ventures. Key Takeaways: 🚀Effectiveness of DTx: Demonstrating real-world impact and patient benefits. 📈Market Impact vs. Financial Returns: A shift from traditional shareholder value to broader market influence. 🛠️SaMD Development Challenges for Pharma: The time-intensive process to launch and scale DTx solutions from scratch. 💡Role of Platforms like Wellthy Therapeutics: Streamlining development and sharpening focus on patient outcomes. 🌐 SaMD Platforms: Accelerating market entry and showcasing ROI effectively. 🎯 Industry Direction: Advocating a pivot towards innovation-driven growth and strategic market approaches. #Wellthytherapeutics #DTxasia #digitaltherapeutics Yoann Sapanel, David Vu, Andy Molnar, Juhee Cho, Chris L. Hardesty, Sean G.(Sungjee) Kang, MD, MPH, Sharon Chan, Scarlett Chen 陈思佳, Dario Heymann, PhD, Tarun Jain, Dr. Matthias Zenker, MD, Rahul Mittal, Shady Ramadan, Dr. Peer Aries, Lasse Lehnert, Danny Kim, PharmD, Tim Shi, Katsuya Hashizume, Yuma Nishikawa, Bechara Saab, Masayo Matsumura

Medine #WeAreMedine #truediversity #corporatemauritius #leadbyexample Bravo to Dhiren Ponnusamy for taking Medine to new heights in the most inclusive manner : 1. Building a truly diversified leadership team in corporate Mauritius (ethnic, gender, age) 2. Role Modelling our Core Values (hipii) 3. Promoting a safe environment for all (no tolerance for harassment/bully/toxicity) 4. Fostering a culture of excellence (continuous improvement through innovation)

Check out the livestream of the first session of TechKnow Invest Roadshow

We enjoyed catching up with the Visiopharm team at #SITC23 last week and getting the inside scoop on their latest platform developments. In this video, Matthew McFarlane & Regan Baird chat about how OracleBio and Visiopharm work together and the importance of key customers to their continued innovation, their new #Phenoplex module, and some exciting upcoming features they have in the works! Watch now 👇 —— #SITC #SITC2023 #visiopharm #digitalpathology #lifescienceconference #scienceevent #immunooncology #cancerresearch #scientificposter

Integration is key when you want a #digitalpathology system that works seamlessly, and Lyell Immunopharma's Trevor Do will be sharing how Lyell's system meets the mark at #IndicaLabs' Bay Area UGM. https://lnkd.in/g6WeEd8i

Cranmore Executive Search played a pivotal role in Horizon's rapid and successful expansion into the European market. "I highly recommend Cranmore," says Chris Serafino. "My contact, Chris Sannwald is a very effective partner and helps me not only find the right candidate and fit, but also is patient with me as my needs grow or change." Read the full case study below on how Cranmore's tailored approach to executive search empowered Horizon Therapeutics' European expansion and fuelled their remarkable success! 📈✨ #SuccessStories #ExecutiveSearch #EuropeanExpansion #HorizonTherapeutics

Pramipexole Phospholipid Magnesome nasal treatment, increased sick animal locomotor activity by 300% vs. oral treatment in 20 Min. Allows rapid and effective delivery of the drug into the brain (in 5 min) to efficiently help motor impairment patients. BioPass Pharma developing an alternative route of drug Intranasal administration, that bypasses the Blood-brain barrier, through the olfactory and nerve pathways.

Benchtalk 2023 Conference Recap ⏪ ⏪ Last week, Karchem Consulting had the pleasure of attending Benchtalk 2023 in Boston! Many thanks to Benchling for their effort in creating an opportunity to connect with other Benchling users and to gain inspiration, knowledge, and cutting-edge insights on leveraging the system to revolutionize R&D. Conference sessions were enlightening, ranging from CRISPR-Cas9 applications to the future of data-driven drug discovery.  We enjoyed listening to speakers from Verve Therapeutics, Genentech, Twist Bioscience, Editas Medicine, GV (Google Ventures), and more. Perhaps the highlight of the event– the unveiling of Benchling Connect and Benchling Bioprocess.  We’re looking forward to learning more about these features as they are available, and seeing how they can meet the needs of the modern-day laboratory environment. With systems that rapidly evolve like Benchling, it can be a full-time job keeping up with the latest releases and products.  Our team stays up to date on the latest features so you don’t have to.  If you’re looking for assistance implementing or optimizing your Benchling environment, reach out on Linkedin or contact us at https://lnkd.in/dVpU8qNm. Overall we look forward to utilizing these new tools and insights and seeing where #JeffyP will go next! #Benchtalk2023 #ELN #LIMS #tech #biopharma #drugdiscovery #conference #networking #bioprocess #data #RND #boston